Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol

NCT04371198 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04371198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04371198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2020
Completion date
August 17, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectum cancer